PRKAA2 and Alzheimer disease: Therefore, given that most drugs are indirect AMPK activators and most of them have multiple targets with a role in AD, it is important that future studies on the role of AMPK activation AD focus on the specific direct AMPK activators as some of the conflicting results may arise from the diversity of additional molecular targets.